microRNAs and death receptors

Cytokine and Growth Factor Reviews

Volumn 19, Issue 3-4, 2008, Pages 303-311

  Park, Sun Mi ^a   Peter, Marcus E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apoptosis; Fas; Let 7; Superclusters; TRAIL

Indexed keywords

CASPASE 3; DEATH RECEPTOR; FAS ANTIGEN; MICRORNA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; HUMAN; INTERNALIZATION; LIPID RAFT; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 44749086842     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2008.04.011     Document Type: Article

References (115)

1. Hengartner M.O. The biochemistry of apoptosis. Nature 407 (2000) 770-776
2. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
3. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 (1999) 441-446
4. Du C., Fang M., Li Y., Li L., and Wang X. Smac a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
5. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102 (2000) 43-53
6. Li L.Y., Luo X., and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412 (2001) 95-99
7. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8 (2001) 613-621
8. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17 (1998) 1675-1687
9. Barnhart B.C., Alappat E.C., and Peter M.E. The CD95 type I/type II model. Semin Immunol 15 (2003) 185-193
10. Algeciras-Schimnich A., Pietras E.M., Barnhart B.C., Legembre P., Vijayan S., Holbeck S.L., et al. Two CD95 tumor classes with different sensitivities to antitumor drugs. Proc Natl Acad Sci USA 100 (2003) 11445-11450
11. Li H., Zhu H., Xu C.J., and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94 (1998) 491-501
12. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 (1998) 481-490
13. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
14. Scaffidi C., Schmitz I., Zha J., Korsmeyer S.J., Krammer P.H., and Peter M.E. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274 (1999) 22532-22538
15. Algeciras-Schimnich A., Shen L., Barnhart B.C., Murmann A.E., Burkhardt J.K., and Peter M.E. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 22 (2002) 207-220
16. Lee K.H., Feig C., Tchikov V., Schickel R., Hallas C., Schutze S., et al. The role of receptor internalization in CD95 signaling. EMBO J 25 (2006) 1009-1023
17. Hueber A.O., Bernard A.M., Herincs Z., Couzinet A., and He H.T. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep 3 (2002) 190-196
18. Legembre P., Daburon S., Moreau P., Moreau J.F., and Taupin J.L. Modulation of Fas-mediated apoptosis by lipid rafts in T lymphocytes. J Immunol 176 (2006) 716-720
19. Muppidi J.R., and Siegel R.M. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat Immunol 5 (2004) 182-189
20. Eramo A., Sargiacomo M., Ricci-Vitiani L., Todaro M., Stassi G., Messina C.G., et al. CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells. Eur J Immunol 34 (2004) 1930-1940
21. Ramaswamy M., Dumont C., Cruz A.C., Muppidi J.R., Gomez T.S., Billadeau D.D., et al. Cutting edge: Rac GTPases sensitize activated T cells to die via Fas. J Immunol 179 (2007) 6384-6388
22. Henkler F., Behrle E., Dennehy K.M., Wicovsky A., Peters N., Warnke C., et al. The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability. J Cell Biol 168 (2005) 1087-1098
23. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14 (1995) 5579-5588
24. Kamitani T., Nguyen H.P., and Yeh E.T. Activation-induced aggregation and processing of the human Fas antigen. Detection with cytoplasmic domain-specific antibodies. J Biol Chem 272 (1997) 22307-22314
25. Feig C., Tchikov V., Schutze S., and Peter M.E. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J 26 (2007) 221-231
26. Chakrabandhu K., Herincs Z., Huault S., Dost B., Peng L., Conchonaud F., et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J 26 (2007) 209-220
27. Peter M.E., Budd R.C., Desbarats J., Hedrick S.M., Hueber A.-O., Newell M.K., et al. The CD95 receptor: apoptosis revisited. Cell 129 (2007) 447-450
28. Alderson M.R., Armitage R.J., Maraskovsky E., Tough T.W., Roux E., Schooley K., et al. Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178 (1993) 2231-2235
29. Freiberg R.A., Spencer D.M., Choate K.A., Duh H.J., Schreiber S.L., Crabtree G.R., et al. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J Invest Dermatol 108 (1997) 215-219
30. Desbarats J., Birge R.B., Mimouni-Rongy M., Weinstein D.E., Palerme J.S., and Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5 (2003) 118-125
31. Park D.R., Thomsen A.R., Frevert C.W., Pham U., Skerrett S.J., Kiener P.A., et al. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J Immunol 170 (2003) 6209-6216
32. Ahn J.H., Park S.M., Cho H.S., Lee M.S., Yoon J.B., Vilcek J., et al. Non-apoptotic signaling pathways activated by soluble Fas ligand in serum-starved human fibroblasts. Mitogen-activated protein kinases and NF-kappaB-dependent gene expression. J Biol Chem 276 (2001) 47100-47106
33. Barnhart B.C., Legembre P., Pietras E., Bubici C., Franzoso G., and Peter M.E. CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J 23 (2004) 3175-3185
34. Lee J.K., Sayers T.J., Back T.C., Wigginton J.M., and Wiltrout R.H. Lack of FasL-mediated killing leads to in vivo tumor promotion in mouse Lewis lung cancer. Apoptosis 8 (2003) 151-160
35. Imamura R., Konaka K., Matsumoto N., Hasegawa M., Fukui M., Mukaida N., et al. Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J Biol Chem 279 (2004) 46415-46423
36. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24 (2000) 227-235
37. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
38. Alvarez-Garcia I., and Miska E.A. MicroRNA functions in animal development and human disease. Development 132 (2005) 4653-4662
39. Wienholds E., and Plasterk R.H. MicroRNA function in animal development. FEBS Lett 579 (2005) 5911-5922
40. Carthew R.W. Gene regulation by microRNAs. Curr Opin Genet Dev 16 (2006) 203-208
41. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
42. Cullen B.R. Transcription and processing of human microRNA precursors. Mol Cell 16 (2004) 861-865
43. Rodriguez A., Griffiths-Jones S., Ashurst J.L., and Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 14 (2004) 1902-1910
44. Weber M.J. New human and mouse microRNA genes found by homology search. FEBS J 272 (2005) 59-73
45. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003) 415-419
46. Yi R., Qin Y., Macara I.G., and Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17 (2003) 3011-3016
47. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet 30 (2002) 363-364
48. Engels B.M., and Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25 (2006) 6163-6169
49. Shell S., Park S.M., Radjabi A.R., Schickel R., Kistner E.O., Jewell D.A., et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci USA 104 (2007) 11400-11405
50. Ambros V. The functions of animal microRNAs. Nature 431 (2004) 350-355
51. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
52. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 (2000) 901-906
53. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 (2000) 86-89
54. Miska E.A., Alvarez-Saavedra E., Townsend M., Yoshii A., Sestan N., Rakic P., et al. Microarray analysis of microRNA expression in the developing mammalian brain. Genome Biol 5 (2004) R68
55. Thomson J.M., Parker J., Perou C.M., and Hammond S.M. A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1 (2004) 47-53
56. Akao Y., Nakagawa Y., and Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29 (2006) 903-906
57. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., et al. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
58. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64 (2004) 3753-3756
59. Mayr C., Hemann M.T., and Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315 (2007) 1576-1579
60. Lee Y.S., and Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21 (2007) 1025-1030
61. Hebert C., Norris K., Scheper M.A., Nikitakis N., and Sauk J.J. High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma. Mol Cancer 6 (2007) 5
62. Giannini G., Kim C.J., Di Marcotullio L., Manfioletti G., Cardinali B., Cerignoli F., et al. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status. Br J Cancer 83 (2000) 1503-1509
63. Chiappetta G., Bandiera A., Berlingieri M.T., Visconti R., Manfioletti G., Battista S., et al. The expression of the high mobility group HMGI (Y) proteins correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10 (1995) 1307-1314
64. Abe N., Watanabe T., Suzuki Y., Matsumoto N., Masaki T., Mori T., et al. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue. Br J Cancer 89 (2003) 2104-2109
65. Sarhadi V.K., Wikman H., Salmenkivi K., Kuosma E., Sioris T., Salo J., et al. Increased expression of high mobility group A proteins in lung cancer. J Pathol 209 (2006) 206-212
66. Park S.M., Shell S., Radjabi A.R., Schickel R., Feig C., Boyerinas B., et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6 (2007) 2585-2590
67. Yu F., Yao H., Zhu P., Zhang X., Pan Q., Gong C., et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131 (2007) 1109-1123
68. Esquela-Kerscher A., and Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6 (2006) 259-269
69. Schickel R, Boyerinas B, Park SM, Peter ME. Oncogene, in press.
70. Hipfner D.R., Weigmann K., and Cohen S.M. The bantam gene regulates Drosophila growth. Genetics 161 (2002) 1527-1537
71. Brennecke J., Hipfner D.R., Stark A., Russell R.B., and Cohen S.M. Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113 (2003) 25-36
72. Xu P., Vernooy S.Y., Guo M., and Hay B.A. The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13 (2003) 790-795
73. Leaman D., Chen P.Y., Fak J., Yalcin A., Pearce M., Unnerstall U., et al. Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development. Cell 121 (2005) 1097-1108
74. Cheng A.M., Byrom M.W., Shelton J., and Ford L.P. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33 (2005) 1290-1297
75. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103 (2006) 2257-2261
76. Chang T.C., Wentzel E.A., Kent O.A., Ramachandran K., Mullendore M., Lee K.H., et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26 (2007) 745-752
77. Chan J.A., Krichevsky A.M., and Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65 (2005) 6029-6033
78. Corsten M.F., Miranda R., Kasmieh R., Krichevsky A.M., Weissleder R., and Shah K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67 (2007) 8994-9000
79. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., and Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133 (2007) 647-658
80. Zhu S., Si M.L., Wu H., and Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282 (2007) 14328-14336
81. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., and Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem (2007)
82. Hayashita Y., Osada H., Tatematsu Y., Yamada H., Yanagisawa K., Tomida S., et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65 (2005) 9628-9632
83. Matsubara H., Takeuchi T., Nishikawa E., Yanagisawa K., Hayashita Y., Ebi H., et al. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26 (2007) 6099-6105
84. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., et al. A microRNA polycistron as a potential human oncogene. Nature 435 (2005) 828-833
85. Tagawa H., Karube K., Tsuzuki S., Ohshima K., and Seto M. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development. Cancer Sci 98 (2007) 1482-1490
86. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., et al. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38 (2006) 1060-1065
87. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., and Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435 (2005) 839-843
88. Sylvestre Y., De Guire V., Querido E., Mukhopadhyay U.K., Bourdeau V., Major F., et al. An E2F/miR-20a autoregulatory feedback loop. J Biol Chem 282 (2007) 2135-2143
89. Coller H.A., Forman J.J., and Legesse-Miller A. "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. PLoS Genet 3 (2007) e146
90. Stanelle J., and Putzer B.M. E2F1-induced apoptosis: turning killers into therapeutics. Trends Mol Med 12 (2006) 177-185
91. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., and Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85 (1996) 537-548
92. Wu X., and Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 91 (1994) 3602-3606
93. Lin W.C., Lin F.T., and Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev 15 (2001) 1833-1844
94. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., et al. Direct coupling of the cell cycle and cell death machinery by E2F. Nat Cell Biol 4 (2002) 859-864
95. Hershko T., and Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279 (2004) 8627-8634
96. Woods K., Thomson J.M., and Hammond S.M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem 282 (2007) 2130-2134
97. Ko L.J., and Prives C. p53: puzzle and paradigm. Genes Dev 10 (1996) 1054-1072
98. Hemann M.T., and Lowe S.W. The p53-Bcl-2 connection. Cell Death Differ 13 (2006) 1256-1259
99. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17 (2007) 1298-1307
100. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 447 (2007) 1130-1134
101. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26 (2007) 731-743
102. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6 (2007) 1586-1593
103. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99 (2002) 15524-15529
104. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102 (2005) 13944-13949
105. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17 (2005) 393-403
106. Cuconati A., Mukherjee C., Perez D., and White E. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. Genes Dev 17 (2003) 2922-2932
107. Taniai M., Grambihler A., Higuchi H., Werneburg N., Bronk S.F., Farrugia D.J., et al. Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells. Cancer Res 64 (2004) 3517-3524
108. Konopleva M., Contractor R., Tsao T., Samudio I., Ruvolo P.P., Kitada S., et al. Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10 (2006) 375-388
109. Kobayashi S., Werneburg N.W., Bronk S.F., Kaufmann S.H., and Gores G.J. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells. Gastroenterology 128 (2005) 2054-2065
110. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353 (2005) 1793-1801
111. Cummins J.M., He Y., Leary R.J., Pagliarini R., Diaz Jr. L.A., Sjoblom T., et al. The colorectal microRNAome. Proc Natl Acad Sci USA 103 (2006) 3687-3692
112. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 (2006) 189-198
113. Mott J.L., Kobayashi S., Bronk S.F., and Gores G.J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26 (2007) 6133-6140
114. Ovcharenko D., Kelnar K., Johnson C., Leng N., and Brown D. Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res 67 (2007) 10782-10788
115. Algeciras-Schimnich A., and Peter M.E. Actin dependent CD95 internalization is specific for Type I cells. FEBS Lett 546 (2003) 185-188